AI Briefing
KO

GPT-5 Reduces Cell-Free Protein Synthesis (CFPS) Costs

·2026.02.05 20:00

Key point

OpenAI partnered with Ginkgo Bioworks to build a GPT-5-based autonomous lab that cut cell-free protein synthesis costs by 40%.

Details

Unlike mathematics or physics, biology requires physical experiments, and the speed of experimental iteration creates a bottleneck for research. To address this, OpenAI connected GPT-5 to Ginkgo Bioworks' cloud lab, building an autonomous experimentation system that independently handles everything from experiment design to execution and learning.

This system was deployed to optimize the cell-free protein synthesis (CFPS) process. GPT-5 designed batches of experiments, robots carried them out, and the resulting data was fed back into the model to propose the next experiment—a closed-loop approach that repeated across a total of 6 experimental cycles.

In this process, the system tested more than 36,000 unique CFPS reaction compositions. As a result, GPT-5 achieved a new technical standard in just 3 experiments, cutting protein production costs by 40% and improving reagent costs by 57%.

This summary was generated automatically by AI. Check the original for the author's claims and context. Copyright belongs to the original author.

Our guide explains how the AI works. Report summary errors, attribution issues, or removal requests via Contact.